306 related articles for article (PubMed ID: 23913880)
1. Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products.
Gamalo MA; Tiwari RC; LaVange LM
Pharm Stat; 2014; 13(1):25-40. PubMed ID: 23913880
[TBL] [Abstract][Full Text] [Related]
2. Non-inferiority and networks: inferring efficacy from a web of data.
Lin J; Gamalo-Siebers M; Tiwari R
Pharm Stat; 2016; 15(1):54-67. PubMed ID: 26639225
[TBL] [Abstract][Full Text] [Related]
3. The network meta-analytic-predictive approach to non-inferiority trials.
Schmidli H; Wandel S; Neuenschwander B
Stat Methods Med Res; 2013 Apr; 22(2):219-40. PubMed ID: 22218367
[TBL] [Abstract][Full Text] [Related]
4. Robust meta-analytic-predictive priors in clinical trials with historical control information.
Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
[TBL] [Abstract][Full Text] [Related]
5. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
6. Some thoughts on sample size: a Bayesian-frequentist hybrid approach.
Gordon Lan KK; Wittes JT
Clin Trials; 2012 Oct; 9(5):561-9. PubMed ID: 22865839
[TBL] [Abstract][Full Text] [Related]
7. Bayesian approach to non-inferiority trials for normal means.
Gamalo MA; Wu R; Tiwari RC
Stat Methods Med Res; 2016 Feb; 25(1):221-40. PubMed ID: 22619277
[TBL] [Abstract][Full Text] [Related]
8. Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomes.
Turner RM; Clements MN; Quartagno M; Cornelius V; Cro S; Ford D; Tweed CD; Walker AS; White IR
Stat Med; 2023 Apr; 42(8):1127-1138. PubMed ID: 36661242
[TBL] [Abstract][Full Text] [Related]
9. A Bayesian non-inferiority approach using experts' margin elicitation - application to the monitoring of safety events.
Aupiais C; Alberti C; Schmitz T; Baud O; Ursino M; Zohar S
BMC Med Res Methodol; 2019 Sep; 19(1):187. PubMed ID: 31533631
[TBL] [Abstract][Full Text] [Related]
10. Design and analysis of non-inferiority mortality trials in oncology.
Rothmann M; Li N; Chen G; Chi GY; Temple R; Tsou HH
Stat Med; 2003 Jan; 22(2):239-64. PubMed ID: 12520560
[TBL] [Abstract][Full Text] [Related]
11. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
Kikuchi T; Gittins J
Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
[TBL] [Abstract][Full Text] [Related]
12. A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority.
Shao Y; Mukhi V; Goldberg JD
Stat Med; 2008 Feb; 27(4):504-19. PubMed ID: 17854052
[TBL] [Abstract][Full Text] [Related]
13. Bayesian approach for assessing non-inferiority in a three-arm trial with pre-specified margin.
Ghosh S; Ghosh S; Tiwari RC
Stat Med; 2016 Feb; 35(5):695-708. PubMed ID: 26434554
[TBL] [Abstract][Full Text] [Related]
14. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
Daimon T
Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
[TBL] [Abstract][Full Text] [Related]
15. An evidential approach to non-inferiority clinical trials.
Wang SJ; Blume JD
Pharm Stat; 2011; 10(5):440-7. PubMed ID: 21928286
[TBL] [Abstract][Full Text] [Related]
16. Some practical considerations in three-arm non-inferiority trial design.
Zhou M; Kundu S
Pharm Stat; 2016 Nov; 15(6):550-559. PubMed ID: 27681603
[TBL] [Abstract][Full Text] [Related]
17. Using historical control information for the design and analysis of clinical trials with overdispersed count data.
Gsteiger S; Neuenschwander B; Mercier F; Schmidli H
Stat Med; 2013 Sep; 32(21):3609-22. PubMed ID: 23722585
[TBL] [Abstract][Full Text] [Related]
18. Issues on the selection of non-inferiority margin in clinical trials.
Hou Y; Wu XY; Li K
Chin Med J (Engl); 2009 Feb; 122(4):466-70. PubMed ID: 19302756
[TBL] [Abstract][Full Text] [Related]
19. Addressing prior-data conflict with empirical meta-analytic-predictive priors in clinical studies with historical information.
Li JX; Chen WC; Scott JA
J Biopharm Stat; 2016; 26(6):1056-1066. PubMed ID: 27541990
[TBL] [Abstract][Full Text] [Related]
20. Bayesian sample size determination in non-sequential clinical trials: Statistical aspects and some regulatory considerations.
Grouin JM; Coste M; Bunouf P; Lecoutre B
Stat Med; 2007 Nov; 26(27):4914-24. PubMed ID: 17559054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]